Cytokines: a group of low MW proteins/peptides secreted by
leukocytes and other cells in response to stimuli. The principal producers are dendritic cells, T helper cells and macrophage.
These magical molecules are important because the
cytokine profile determines disease outcome (survival) and cytokine therapy is increasingly used to save lives.
Human cytokines produced by recombinant DNA
technology are the ultimate natural products- much more natural than those obtained from plants in rain forests or organisms that inhabit the sea.
Cytokines are extraordinarily powerful, affecting gene
activation in target cells at picomolar concentrations (10-12 M)!!!! Beyond nanograms (a billionth of a gram) by 1/1000. Very high dissociation constants= very high affinity.
Interleukins: a group of cytokines secreted by leukocytes that
primarily affect the growth and differentiation of various hematopoietic and immune system cells.
Chemokines: cytokines that primarily mediate chemotaxis for
different leukocytes and regulate the expression and /or adhesiveness of leukocyte integrins.
Note interleukin 8, a cytokine that is both a chemokine and
obviously an interleukin.
Chemokine receptor CCR5 that is mutated via deletion to
CCR5 delta 32 ( in homozygous recessive) whites- makes them resistant to infection by HIV. Why? CCR5 is the co-receptor for HIV to enter cells.
Normal ligands for CCR5 are, RANTES, MIP-1, and MIP-1,
and they are able to suppress HIV-1 infection in vitro. In individuals infected with HIV, CCR5-using viruses are the predominant species isolated during the early stages of viral infection
News Flash from Immunoleaks!
New HIV drugs, called CCR5 receptor antagonists, have been
designed to interfere with the interaction between CCR5 and HIV. Examples: Vicriviroc (Schering Plough), Aplaviroc (GW- 873140) (GlaxoSmithKline) and Maraviroc (UK-427857) (Pfizer). Note: suffix viroc
How did these drug companies develop these antagonists?
Mother Nature taught them- page 114 7e depicts natural
cytokine inhibitors of IL-1 (a proinflammatory cytokine induces type I anti-viral interferons). Two types: 1. Receptors that do not have signaling domains 2. Soluble forms of IL-1 or other cytokine binding proteins that the drug companies can mimic.
Why did she develop these? To soak up excess cytokine
and thus fine tune an immune response. IL-1 is highly proinflammatory (the fever cytokine) and unchecked can be fatal. Classification of cytokines: A. Autocrine: binds to same cell that secreted it. IL-2 autocrine for CD4+.
B. Paracrine: affects a nearby cell. IL-1 from mac affects
CD4+
C. Endocrine: affects a distant cell. Mac IL-1 affects cells in
hypothalamus of the brain.
III. General Properties/Actions of Cytokines: Figs 4.1, 4.2 4.3
7e (Fig. 12-2 6e)
A. Pleiotropy: many different biological actions, depending on
the target cell B. Redundancy: when two or more cytokines have the same effect.
C. Synergism: combined effects of cytokines is greater than
added effects
D. Antagonism: effects of one cytokine inhibits the action of
another.
E. Cascade effect: one cytokine causes a group of cells to
release other cytokines which can cause other cells to release other cytokines etc.
Cytokines activate specific T helper cells
Cell Activation via cytokines alters expression of both
Receptors and Adhesion Molecules on a variety of immune cells
The Immunological Synapse- directs the release of cytokines
from APC to T or Th to B or Tc.
Youtube video of synapse at:
https://youtu.be/gKFXTJ9MjFg Methods Used to map the Secretome- the proteins that are secreted from activated cells. see advances in pages 111 to 112.
The Cytokine assay technology in Fig 1 on page 112 7e is
commonly called the Cytometric Bead Array or Multiplex assay. What is the principle of the bead assay? Antibodies immobilized on beads that fluoresce at different wavelengths.
Function of cytokines Table 4-1 in Kuby 7e (12-1 in 6e):
above is table 4-1 in 7th edition Page 119 Discovery : Interferons (type I antiviral was first cytokine discovered, purified and produced by Genentech/Roche. Discovered by two scientist who published in French, not recognized at time. Issacs and Lindenman 1950s chick chorioallantoic membrane (CAM) for growth of influenza discovered that heat inactivated influenza induced an interfering molecule when CAM challenged with live flu virus. 1978- Roche scientists (Dr. Weissman) and others purified IFN and cloned the gene. Genetech put the human gene into E. coli. Roche then bought Genetech for 48 billion dollars.
Type II Interferon gamma or immune interferon: page 120
From: activated T and NK cells, activates macrophages and dendritic cells and elicits a Th1 or cytotoxic T cells response. NK cells are initially one of largest sources and they in turn activate macs/dends to produce a lot of it.
IFN gamma induces intracellular killing of microbes in
macs/dendritic and licenses Dendritic cells for cross presentation of extracellular obtained antigens in MHCII= licensing of dendritic cells.
All interferons induce high levels of MHC molecules!
Cytokine Receptors: Five Families of receptor proteins-
we will look at only two.
Class I = immune and hematopoietic receptors for majority of
cytokine binding receptors such as most interleukins, GM-CSF, G-CSF etc.
On their extracellular domain they have:
a. conserved cysteine residues- CCCC
b. Conserved sequence of Trp-Ser-X-Trp-Ser called
(WSXWS) They normally have two peptide chains:
a. Cytokine specific subunit that binds the cytokine
b. Signal transducing subunit- present on cytokine
receptors (recall none on B and T cell receptors)
Note: A remarkable variety of receptors is achieved by
different combinations of common signal transducers with other receptor peptides. Is the immunological synapse thus more sophisticated and intricate than the neuronal synapse? I certainly think so, you will too when you study this material. Which synapse is more critical to your survival? They share common signal-transducing subunits, thus explaining some of the redundancy and antagonism exhibited by some cytokines Check fig. 4-9 (12-7a in 6e) and note the shared colors (subunits) of the signal transducing unit among the family Note common signal-transducing subunit in beta blue, but unique cytokine binding subunit for different cytokines. Accounts for redundancy (same effects) among different cytokines.
IL-2 receptor- as key example of a class I receptor:
Importance: IL-2 is key cytokine for proliferation of T
cells a. It exists as a trimer (alpha, beta and gamma chains) following binding of TCR to antigen. Trimer form binds IL-2 with high affinity and T cells are greatly and more selectively activated. Other cells like NK express intermediate affinity receptor. Check out fig. 12-9 IL-2R alpha (just the alpha chain as receptor) is first seen in early T cell development/low level activation. IL-2R alpha is also known as CD25, High levels on the surface of T cells (bright fluorescence in flow cytometer) indicates the presence of highly activated T cells with IL-2R in trimer form ( An antibody to identify CD25 is called anti-TAC
From Fig. 4-8 7e
Class II Cytokine Family of Receptors: interferons
and the Common JAK-STAT Signalling family.
Cytokines activate Class I and class II receptors through the
the JAK-STAT pathway=Janus Kinase= JAK Signal Transducers and Activators of Transcription= STAT.
Note: Signal transduction mediated by cytokine receptors-
there are inactive kinases called Janus (Roman God two faces) tyrosine kinases that are associated with the cytoplasmic tails of the receptors. So a similar story then follows wherein phosporylation of DNA binding proteins, in this case STAT (Signal Transducers ) occurs. STAT then binds to specific genes and they are transcribed.
Above is also Fig 4-11 in 7edition.
TNF Cytokine Family- tumor necrosis family of cytokines (pg. 123). Unusual: Often anchored in membrane of effector cell, but can be cleaved to become soluble:
TNF alpha: proinflammatory from macrophage in response to
infection= killing cancer cells and chronic inflammation
TNF beta: also known as Lymphotoxin alpha- from activated
lymphocytes, activates other cells to upregulate MHC and adhesion molecules.
Puzzling Receptor response: TNF-R1 can deliver either
activating or death promoting signals??????? Mechanisms described in figure 4-14 which you do NOT NEED to Know) Response: Depends on the overall cytokine polarizing environment etc.
Fas Receptor FasL interaction (page 125) member of TNF
family-more on this later: Think death, death, death of cancer cells BUT ALSO activated T cells through activation of the Caspase cascade= apoptosis.
Fas L induces formation of : the death-Inducing Signaling
Complex or DISC) which consists of FAS+FADD+Procaspase 8 (fig. 4-13)
Programmed cell death For shutting down the immune
response! Sounds counterproductive? Activation induced cell death: Activated lymphocytes up- regulate Fas receptor containing death domains- See fig. 4-13. Why? One of many mechanisms to shut down an immune response. Note: Cancer cells express PDL-1 or programmed death ligand. Who do you suppose is their target?
Th17- Recently discovered Cytokine:
Important in inflammation, especially asthma colitis, Crohns
Disease and other immune diseases. Also a family A-F. see table 4-5 but do not memorize.
TGF- + IL-6 is a crucial cytokine for Th17 cell
development and for T 17 cells. This same cytokine TGF beta released from T reg cells shuts down an immune response when IL-10 is present! Concept: polarizing mixtures of cytokines have different effects depending on the microenvironment and cells present.
Cytokine Related Diseases- page 134.
a. Bacterial Septic Shock: infection with gram negative bacteria possess LPS which causes macrophages to release IL-1 and TNF alpha as an overproduction. = disseminated intravascular coagulation (DIC) or lots of blood clots in the vascular system, A drop in blood pressure, inability to each hospital food and then the patient dies (over 70,000 patients/year die )-$5 billion market for biotech firms making monoclonal antibodies to TNF or finding other ways to block runaway inflammation. b. IL-1Ra or receptor antagonist has been developed (page 133) It looks like the receptor and lowers mortality from 45% to 16%! c. Inflammatory cytokine levels may be increased in disease states
a. Bacterial toxic shock also induced by
superantigens b. Potential involvement in rheumatoid arthritis and Type 2 diabetes c. Implication in lymphoid and myeloid cancers d. 1918 H1N1 influenza pandemic and cytokine storms e. Evidence of cytokine involvement in Severe acute respiratory syndrome (SARS)
Viruses Exploit Cytokine Activity- virokines and viral
encoded cytokine receptors!!
Most of these receptor homologous proteins are either
secreted glycoproteins or are located at the infected cell surface. It is believed that the function of these viral receptor mimics is to intercept the activity of the cognate cytokine, thus effectively short-circuiting host immune responses to the viral infection. Cytokine Therapy: Clinical Focus Therapy with Interferons on page 322 6th edition, page 120 and 121 in 7e. Read the Clinical Focus especially use of : Interferon alpha in Chronic myelogenous leukemia,Kaposis
Interferon beta or Tysabri in MS therapy.
If cytokine levels are related to disease, therapies to
reduce cytokine levels can treat disease Rheumatoid arthritis Soluble TNF- receptor (Enbrel) Monoclonal antibodies against TNF- (Remicade and Humira)
Prevention of transplantation rejection- Thanks to a student in the class, I looked this up: Monoclonal antibodies against the chain of IL-2R (Simulect and Zenapax) Alton had asked why we cant use antibody against IL-2 to block T cell? We block the receptor, not the cytokine. Note: we do NOT block the gamma chain common to many cytokine receptors. Clever.
Note: Interferons alpha and beta cause depression. They
stimulate an enzyme on macs/dends called IDO which converts/depletes tryptophan. If low tryptophan then no serotonin.
Conversion of tryptophan to Kyurenine is toxic to T cells and
thus could benefit Tc mediated diseases like multiple sclerosis. Cytokines, Obesity, Adult Diabetes : Clinical Focus page 136
1. Adipocytes produce TNF alpha constituitively
2. TNFalpha levels drop with weight loss 3. TNF signaling in adipocytes inhibits insulin receptors in fat/liver cells so no glucose is taken up= sweet urine 4. Interleukin 6 inhibits insulin response in hepatocytes where glucose is stored and stimulates Th17 to secrete IL- 17. 5. Interleukin 17 induces monocytes to produce more IL-6 Maintenance of an inflammatory state as fat cells lyse and release inflammatory lipids and other DAMPS